loading page

Enhanced immunity against to SARS-CoV-2 in returning ex-patriot Chinese
  • +22
  • Jiufeng Sun,
  • Runyu Yuan,
  • Huimin Chen,
  • Lina Yi,
  • Xinxin Li,
  • Ximing Hu,
  • Xing Li,
  • Huan Zhang,
  • Pingping Zhou,
  • Chumin Liang,
  • Huifang Lin,
  • Lilian Zeng,
  • Xue Zhuang,
  • QianQian Ruan,
  • Yueling Chen,
  • Yingyin Deng,
  • Zhe Liu,
  • Jing Lu,
  • Jianpeng Xiao,
  • Liang Chen,
  • Xincai Xiao,
  • Jing Li,
  • Baisheng Li,
  • Yan Li,
  • Jianfeng He
Jiufeng Sun
Guangdong Center for Disease Control and Prevention

Corresponding Author:sunjiuf@163.com

Author Profile
Runyu Yuan
Guangdong Center for Disease Control and Prevention
Author Profile
Huimin Chen
Guangdong Center for Disease Control and Prevention
Author Profile
Lina Yi
Guangdong Center for Disease Control and Prevention
Author Profile
Xinxin Li
Guangdong Center for Disease Control and Prevention
Author Profile
Ximing Hu
Guangdong Center for Disease Control and Prevention
Author Profile
Xing Li
Guangdong Center for Disease Control and Prevention
Author Profile
Huan Zhang
Guangdong Center for Disease Control and Prevention
Author Profile
Pingping Zhou
Guangdong Center for Disease Control and Prevention
Author Profile
Chumin Liang
Guangdong Center for Disease Control and Prevention
Author Profile
Huifang Lin
Guangdong Center for Disease Control and Prevention
Author Profile
Lilian Zeng
Guangdong Center for Disease Control and Prevention
Author Profile
Xue Zhuang
Guangdong Center for Disease Control and Prevention
Author Profile
QianQian Ruan
Guangdong Center for Disease Control and Prevention
Author Profile
Yueling Chen
Guangdong Center for Disease Control and Prevention
Author Profile
Yingyin Deng
Guangdong Center for Disease Control and Prevention
Author Profile
Zhe Liu
Guangdong Center for Disease Control and Prevention
Author Profile
Jing Lu
Guangdong Center for Disease Control and Prevention
Author Profile
Jianpeng Xiao
Guangdong Center for Disease Control and Prevention
Author Profile
Liang Chen
Guangdong Center for Disease Control and Prevention
Author Profile
Xincai Xiao
Guangzhou Medical University
Author Profile
Jing Li
Sinovac Life Sciences Co Ltd
Author Profile
Baisheng Li
Guangdong Center for Disease Control and Prevention
Author Profile
Yan Li
Guangdong Center for Disease Control and Prevention
Author Profile
Jianfeng He
Guangdong Center for Disease Control and Prevention
Author Profile

Abstract

Background Global COVID-19 vaccination programs effectively contain the fast spread of the SARS-CoV-2. Characteristic the immunity status of returned populations will favor for understanding the achievement of herd immunity and long-term management of COVID-19 in China. Methods Returning travellers were recruited from 7 quarantine stations in Guangzhou, China. The immunity statuses of participants were determined through Competitive ELISA, Micro-Neutralization Assay and Enzyme-Linked FluoroSpot Assay. Results A total of 272 subjects were involved in questionnaire survey, in which 235 (86.4%) were returning ex-patriot Chinese and 37 (13.6%) were foreigners. Blood and throat swabs specimens were collected from each of 108 returning ex-patriot Chinese. The neutralizing antibody against SARS-CoV-2 was detected in ~90% of returning ex-patriot Chinese, either in the primary or the homologous and heterologous booster vaccination group. The serum NAb titers of them were significantly decreased against SARS-CoV-2 Omicron BA.5, BF.7, BQ.1 and XBB.1 compare with prototype virus. However, memory T cell responses including specific IFN-γ and IL-2 were no differences in either group. Smoking, drinking, SARS-CoV-2 infection, COVID-19 vaccination, and the time interval between last vaccination and the sampling were independent influencing factors for NAb titers against prototype SARS-CoV-2 and variants of concerns. The dose of vaccination was the unique common influencing factor for Omicron variants. Conclusions The herd immunity was established in returning ex-patriot Chinese who exposure to the complicated infection and vaccination circumstance. Domestic residents will benefit from booster of COVID-19 vaccines either in homologous and heterologous vaccination after re-opening of China, as well as breakthrough infection.